Punicalagin, a polyphenol from pomegranate fruit, induces growth inhibition and apoptosis in human PC-3 and LNCaP cells

Chemico-Biological Interactions

Volumn 274, Issue , 2017, Pages 100-106

  Adaramoye, Oluwatosin ^a,b   Erguen, Bettina ^a   Nitzsche, Bianca ^a   Höpfner, Michael ^a   Jung, Klaus ^a,c   Rabien, Anja ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c Berlin Institute for Urologic Research   (Germany)

Author keywords

Anti angiogenic effects; Apoptosis; Prostate cancer cells; Punicalagin

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; LACTATE DEHYDROGENASE; POLYPHENOL; PUNICALAGIN; UNCLASSIFIED DRUG; ANTIOXIDANT; PLANT EXTRACT; TANNIN;

ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CULTURE; CELL VIABILITY; CHORIOALLANTOIC MEMBRANE ASSAY; CHORIOALLANTOIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; ENRICHMENT CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID PEROXIDATION; LNCAP CELL LINE; MALE; NONHUMAN; PC 3 CELL LINE; POMEGRANATE; PROSTATE CANCER CELL LINE; PROSTATE CELL LINE; PROTEIN EXPRESSION; RAT; ANGIOGENESIS; ANIMAL; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; FRUIT; ISOLATION AND PURIFICATION; LYTHRACEAE; METABOLISM; TUMOR CELL LINE; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CASPASE 3; CASPASE 8; CELL LINE, TUMOR; CELL PROLIFERATION; DNA FRAGMENTATION; FRUIT; HUMANS; HYDROLYZABLE TANNINS; LIPID PEROXIDATION; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PLANT EXTRACTS; POLYPHENOLS; PUNICACEAE; RATS; RATS, WISTAR;

EID: 85024113570     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2017.07.009     Document Type: Article

References (41)

1. Adams, L.S., Seeram, N.P., Aggarwal, B.B., Takada, Y., Sand, D., Heber, D., Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J. Agric. Food Chem. 54 (2006), 980–985.
2. Adhami, V.M., Khan, N., Mukhtar, H., Cancer chemoprevention by pomegranate: laboratory and clinical evidence. Nutr. Cancer 61 (2009), 811–815.
3. Adhami, V.M., Siddiqui, I.A., Syed, D.N., Lall, R.K., Mukhtar, H., Oral infusion of pomegranate fruit extract inhibits prostate carcinogenesis in the TRAMP model. Carcinogenesis 33 (2012), 644–651.
4. Afaq, F., Saleem, M., Krueger, C.G., Reed, J.D., Mukhtar, H., Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Int. J. Cancer 113 (2005), 423–433.
5. Aharoni, S., Lati, Y., Aviram, M., Fuhrman, B., Pomegranate juice polyphenols induce a phenotypic switch in macrophage polarization favoring a M2 anti-inflammatory state. Biofactors 41 (2015), 44–51.
6. Ahaghotu, C., Tyler, R., Sartor, O., African american participation in oncology clinical trials–focus on prostate cancer: implications, barriers, and potential solutions. Clin. Genitourin. Cancer 14 (2016), 105–116.
7. Aqila, F., Munagalaa, R., Vadhanama, M.V., Kausara, H., Jeyabalana, J., Schultzc, D.J., et al. Anti-proliferative activity and protection against oxidative DNA damage by punicalagin isolated from pomegranate husk. Food Res. Int. 49 (2012), 345–353.
8. Buchholz, M., Gress, T.M., Molecular changes in pancreatic cancer. Expert Rev. Anticancer Ther. 9 (2009), 1487–1497.
9. Chen, Y.J., Tsai, Y.M., Kuo, C.D., Ku, K.L., Shie, H.S., Liao, H.F., Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect. Life Sci. 85 (2009), 642–651.
10. Choumessi, A.T., Danel, M., Chassaing, S., Truchet, I., Penlap, V.B., Pieme, A.C., et al. Characterization of the antiproliferative activity of Xylopia aethiopica. Cell Div. 7 (2012), 1–8.
11. Clark, A.G., Vignjevic, D.M., Modes of cancer cell invasion and the role of the microenvironment. Curr. Opin. Cell Biol. 36 (2015), 13–22.
12. Elmore, S., Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35 (2007), 495–516.
13. Gerlier, D., Thomasset, N., Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods 94 (1986), 57–63.
14. Gil, M.I., Tomas-Barberan, F.A., Hess-Pierce, B., Holcroft, D.M., Kader, A.A., Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food Chem. 48 (2000), 4581–4589.
15. Gloesenkamp, C.R., Nitzsche, B., Ocker, M., Di Fazio, P., Quint, K., Hoffmann, B., et al. AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors. Int. J. Oncol. 40 (2012), 876–888.
16. Gulcin, I., Antioxidant activity of L-adrenaline: a structure–activity insight. Chem. Biol. Interact. 179 (2009), 71–80.
17. Gulcin, I., Antioxidant properties of resveratrol: a structure–activity insight. Innovative Food Sci. Emerg. Technol. 11 (2010), 210–218.
18. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
19. Heber, D., Pomegranate ellagitannins. Benzie, I.F.F., Wachtel-Galor, S., (eds.) Herbal Medicine: Biomolecular and Clinical Aspects, 2011, CRC Press, Boca Raton, FL.
20. Heber, D., Pomegranates: Ancient Roots to Modern Medicine. 2006, CRC Press, Boca Raton, FL.
21. Höpfner, M., Lemmer, K., Jansen, A., Hanski, C., Riecken, E.O., Gavish, M., et al. Expression of functional P2-purinergic receptors in primary cultures of human colorectal carcinoma cells. Biochem Biophys. Res. Commun. 251 (1998), 811–817.
22. Jurenka, J.S., Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern. Med. Rev. 13 (2008), 128–144.
23. Kasimsetty, S.G., Bialonska, D., Reddy, M.K., Ma, G., Khan, S.I., Ferreira, D., Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J. Agric. Food Chem. 58 (2010), 2180–2187.
24. Khan, N., Hadi, N., Afaq, F., Syed, D.N., Kweon, M.H., Mukhtar, H., Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis 28 (2007), 163–173.
25. Kulkarni, A.P., Mahal, H.S., Kapoor, S., Aradhya, S.M., In vitro studies on the binding, antioxidant, and cytotoxic actions of punicalagin. J. Agric. Food Chem. 55 (2007), 1491–1500.
26. Lin, C.C., Hsu, Y.F., Lin, T.C., Hsu, F.L., Hsu, H.Y., Antioxidant and hepatoprotective activity of punicalagin and punicalin on carbon tetrachloride-induced liver damage in rats. J. Pharm. Pharmacol. 50 (1998 Jul), 789–794.
27. Lin, C.C., Hsu, Y.F., Lin, T.C., Hsu, H.Y., Antioxidant and hepatoprotective effects of punicalagin and punicalin on acetaminophen-induced liver damage in rats. Phytother. Res. 15 (2001), 206–212.
28. Mensor, L.I., Menezes, F.S., Leitao, G.G., Reis, A.S., dos Santos, T., Coube, C.S., et al. Screening of Brazilian Plants extracts for antioxidants activity by the use of DPPH free radical method. Phytother. Res. 15 (2001), 127–130.
29. Nitzsche, B., Gloesenkamp, C., Schrader, M., Ocker, M., Preissner, R., Lein, M., et al. Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours. Br. J. Cancer 103 (2010), 18–28.
30. Nobili, S., Lippi, D., Witort, E., Donnini, M., Bausi, L., Mini, E., et al. Natural compounds for cancer treatment and prevention. Pharmacol. Res. 59 (2009), 365–378.
31. Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem 95 (1979), 351–358.
32. Pirzad, G., Jafari, M., Tavana, S., Sadrayee, H., Ghavami, S., Shajiei, A., et al. The role of Fas- FasL signaling pathway in induction of apoptosis in patients with sulfur mustard-induced chronic bronchiolitis. J. Toxicol., 2010, 2010, 373612.
33. Rodrigues, J., Abramjuk, C., Vasquez, L., Gamboa, N., Dominguez, J., Nitzsche, B., et al. New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancer. Pharm. Res. 28 (2011), 907–919.
34. Shirode, A.B., Kovvuru, P., Chittur, S.V., Henning, S.M., Heber, D., Reliene, R., Antiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks. Mol. Carcinog. 53 (2014), 458–470.
35. Stowe, C.B., The effects of pomegranate juice consumption on blood pressure and cardiovascular health. Complement. Ther. Clin. Pract. 17 (2011), 113–115.
36. Svejda, B., Aguiriano-Moser, V., Sturm, S., et al. Anticancer activity of novel plant extracts from Trailliaedoxa gracilis (W. W. Smith & Forrest) in human carcinoid KRJ-I cells. Anticancer Res. 30 (2010), 55–64.
37. Syed, D.N., Afaq, F., Mukhtar, H., Pomegranate derived products for cancer chemoprevention. Semin. Cancer Biol. 17 (2007), 377–385.
38. Yaidikar, L., Thakur, S., Punicalagin attenuated cerebral ischemia-reperfusion insult via inhibition of proinflammatory cytokines, up-regulation of Bcl-2, down-regulation of Bax, and caspase-3. Mol. Cell Biochem 402 (2015), 141–148.
39. Yeh, C.C., Yang, J.I., Lee, J.C., Tseng, C.N., Chan, Y.C., Hseu, Y.C., et al. Anti-proliferative effect of methanolic extract of Gracilaria tenuistipitata on oral cancer cells involves apoptosis, DNA damage, and oxidative stress. BMC Complement. Altern. Med., 12, 2012, 142.
40. Zahin, M., Ahmad, I., Gupta, R.C., Aqil, F., Punicalagin and ellagic acid demonstrate antimutagenic activity and inhibition of benzo[a]pyrene induced DNA adducts. Biomed. Res. Int., 2014, 2014, 467465, 10.1155/2014/467465.
41. Zhang, X., Lin, D., Jiang, R., Li, H., Wan, J., Li, H., Ferulic acid exerts antitumor activity and inhibits metastasis in breast cancer cells by regulating epithelial to mesenchymal transition. Oncol. Rep. 36 (2016), 271–278.